Cardiac Imaging & Structural Heart Interventions 

Description: 

This product offers access to a cutting-edge series of presentations, originally recorded during ASE's 2025 Scientific Sessions, providing state-of-the-art insights into the diagnosis, strategic decision-making, and execution of complex structural heart interventions, anchored by advanced cardiac imaging technologies. Designed for echo experts, cardiologists, and surgeons, this collection navigates the rapidly evolving landscape of valvular heart disease treatment in 2025 and beyond.

• Rapid-Fire Rheumatic Review: Imaging Innovations for Rheumatic Heart Disease (ASEAN & PSE Joint Session)
• Navigating The Mitral Maze: A Comprehensive Exploration of Stenosis (KSE Joint Session)
• State-of-the-Art Imaging and Management of Aortic Regurgitation: What You Need to Know in 2025
• Abstracts: Valve and Structural Heart Disease 1 & 2
• ASE Guideline: Performance of Mitral Valve Edge-To-Edge Transcatheter Repair (MV-TEER)
• State-of-the-Art Transcatheter Mitral and Tricuspid Valve Interventions: Expect the Unexpected (EACVI Joint Session)
• How to Assess and Perform Transcatheter Tricuspid Interventions: Tips and Tricks from The Experts (SCCT Joint Session)
• Tales From the Other Side of the Drapes- Intraoperative Echocardiography in Surgical Decision-Making (SCA Joint Session)
• Cutting-edge Insights: Imaging for Left Atrial Appendage Occlusion Success
• Critical Thinking in the Diagnosis of Valvular Heart Disease
• Interventional Echo TED Talks - Where We Are in 2025 and Tomorrow's Vision!

CME Information:10.0 AMA PRA Category 1 Credit(s)™

CME Expiration: November 11, 2028.  CME Credits must be claimed by this date.

Accreditation Statement & CME Information (Pending Approval)

The American Society of Echocardiography is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The American Society of Echocardiography designates this activity for a maximum of 10.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program, the American Board of Pediatrics (ABP) MOC program, and/or the American Board of Anesthesiology’s (ABA) Maintenance of Certification in Anesthesiology Program® or MOCA 2.0®. It is ASE’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM and ABP MOC points and/or ABA MOCA 2.0®.   Physicians will earn MOC and/or MOCA 2.0 points equivalent to the amount of CME credits claimed for the activity.

ARDMS and CCI recognize ASE’s certificates and have agreed to honor the CME credit hours toward their registry requirements for sonographers.

Disclosures:

ASE is committed to ensuring that its educational mission, and all accredited continuing educational programs provide a protected space to learn, teach, and engage in scientific discourse free from influence from organizations that may have an incentive to insert commercial bias into education.

While a monetary or professional affiliation with an ineligible company does not necessarily influence a speaker’s presentation, the Standards for Integrity and Independence in Accredited Continuing Education and policies of the ACCME require that all financial relationships with ineligible companies* be identified and mitigated prior to engaging in an accredited CE activity. In accordance with these policies, ASE actively identified relevant financial relationships between faculty in control of this accredited CE activity and ineligible companies and implemented mitigation strategies to eliminate any potential influence from persons or organizations that may have an incentive to insert commercial bias in this activity. (*Companies that are ineligible to be accredited in the ACCME System (“ineligible companies”) are those whose primary business is producing, marketing, selling, reselling, or distributing healthcare products used by or on patients.)

The following faculty members have no relevant financial relationships with ineligible companies:

All relevant financial relationships with ineligible companies listed for the following faculty members have been mitigated:

• Bo Xu; Bristol Myers Squibb (Speaker/Speaker's Bureau)
• Jae Oh; Anumana (Royalties/Patent Beneficiary)
• Kevin Hodges; Intuitive Surgical (Consultant or Advisor)
• Kiran Belani; GE Healthcare (Consultant or Advisor)
• Konstantinos Koulogiannis; Edwards Lifesciences (Consultant or Advisor); Abbott (Consultant or Advisor); 4C Medical (Stockholder)
• Markus Scherer; Abbott (Speaker/Speaker's Bureau); Boston Scientific (Speaker/Speaker's Bureau); Edwards Lifesciences (Speaker/Speaker's Bureau)
• Megan Kraushaar; Epsilon (Speaker/Speaker's Bureau); MyoKardia (Consultant/Advisor)
• Noreen Kelly; Boston Scientific (Speaker/Speaker's Bureau); Abbott (Speaker/Speaker's Bureau)
• Omar Khalique; Edwards (Consultant or Advisor); Siemens (Consultant or Advisor)
• Steffan Peterson; Circle Cardiovascular Imaging (Consultant or Advisor)
• Linda Gilliam; Medtronic (Consultant or Advisor)
• Rebecca Hahn; Abbott Vascular, Boston Scientific, Edwards Lifesciences, Medtronic, Philips Healthcare (Speaker/Speaker's Bureau)
• Rhonda Miyasaka; Abbott (Consultant or Advisor); Edwards (Speaker/Speaker's Bureau)

Members of the ASE CME Committee members (not serving as faculty) do not have any financial relationships with ineligible companies.  Click here for a list of these members.

None of the ASE staff who were involved in the planning and implementation of this educational activity have relevant financial relationship(s) to disclose with ineligible companies.  Click here for a list of ASE staff members.

No commercial support was provided for this activity.

• Contact:
  ASE Learning Hub